Tariffs as a turning point

Navigating tariffs and transforming MedTech for the digital future

In early 2025, the United States introduced sweeping tariffs that have shaken global industries—MedTech included. For a sector dependent on global supply chains and hardware-centric models, the impact has been immediate and severe both for U.S. companies and the global organizations that do business with them.

To navigate this storm, companies need to think not just tactically, but strategically.

In this new POV, Tariffs as a turning point Capgemini’s life sciences teams guide clients through these periods of turbulence by helping them transition to digital solutions that offer higher margins, reduced risks, and quicker responsiveness.

Being digital-first can make the difference in finding a route.